SA PRO
Free Account
Organon & Co.OGNNYSE
LOADING
|||
OverviewNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts are neutral — opinion is divided on direction.

Consensus Rating
Hold
8 analysts·Limited coverage
50%
Rating Distribution
Strong Buy
00%
Buy
450%
Hold
225%
Sell
225%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Dec 8, 2025Barclays
Organon initiated with an Underweight at Barclays
Target:$7.50
+2.9%from $7.29
Oct 27, 2025Piper Sandler
Piper double downgrades Organon to Underweight after CEO resignation
Target:$5.00
-29.9%from $7.13
May 15, 2025Piper Sandler
Organon price target lowered to $18 from $24 at Piper Sandler
Target:$18.00
+105.2%from $8.77
May 5, 2025Morgan Stanley
Organon price target lowered to $10 from $15 at Morgan Stanley
Target:$10.00
+14.7%from $8.72
Apr 29, 2024Piper Sandler
Organon & Co. (OGN) PT Raised to $24 at Piper Sandler
Target:$24.00
+27.4%from $18.84
Jun 26, 2023Piper Sandler
Check Out 3 Health Care Stocks With Over 4% Dividend Yields From Wall Street's Most Accurate Analysts
Target:$34.00
+67.0%from $20.36

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance